CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases
Bettayeb, K, Oumata, N, Echalier, A, Ferandin, Y, Endicott, J A, Galons, H, Meijer, L
Published in Oncogene (02.10.2008)
Published in Oncogene (02.10.2008)
Get full text
Journal Article
7-Bromoindirubin-3′-oxime induces caspase-independent cell death
RIBAS, J, BETTAYEB, K, SKALTSOUNIS, A.-L, BOIX, J, MEIJER, L, FERANDIN, Y, KNOCKAERT, M, GARROFE-OCHOA, X, TOTZKE, F, SCHÄCHTELE, C, MESTER, J, POLYCHRONOPOULOS, P, MAGIATIS, P
Published in Oncogene (12.10.2006)
Published in Oncogene (12.10.2006)
Get full text
Journal Article
CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells
Bettayeb, Karima, Baunbæk, Dianne, Delehouze, Claire, Loaëc, Nadège, Hole, Alison J, Baumli, Sonja, Endicott, Jane A, Douc-Rasy, Setha, Bénard, Jean, Oumata, Nassima, Galons, Hervé, Meijer, Laurent
Published in Genes & cancer (01.04.2010)
Published in Genes & cancer (01.04.2010)
Get full text
Journal Article
N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine
Bettayeb, Karima, Sallam, Hatem, Ferandin, Yoan, Popowycz, Florence, Fournet, Guy, Hassan, Moustapha, Echalier, Aude, Bernard, Philippe, Endicott, Jane, Joseph, Benoît, Meijer, Laurent
Published in Molecular cancer therapeutics (01.09.2008)
Published in Molecular cancer therapeutics (01.09.2008)
Get full text
Journal Article
Meriolins, a new class of cell death-inducing, cyclin dependent kinase inhibitors with enhanced selectivity for cyclin-dependent kinases
Ferandin O. Lozach J. C. Morris S. Mateo-Lozano P. Drueckes C. Schächtele M. H. G. K. Bettayeb O. M. Tirado S. Marionneau-Lambot, Y.
Published in Cancer research (Chicago, Ill.) (2007)
Get full text
Published in Cancer research (Chicago, Ill.) (2007)
Journal Article